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Tobacco smoke causes lung cancer and has
been classiﬁed as a group A carcinogen under
the U.S. Environmental Protection Agency’s
(EPA) carcinogen assessment guidelines (1).
Various studies have shown that tobacco
smoke is an important source of several well-
established carcinogens, including benzene,
1,3-butadiene, and N-nitrosamines (2–11).
Exposure to tobacco smoke-related
chemicals is widely believed to pose signiﬁ-
cant health risks. Studies suggest, for exam-
ple, that prenatal or childhood passive
exposure to parents’ smoking significantly
increases the risk of childhood and adult
cancers (12–15), and nonsmoking spouses of
smokers have an increased risk of lung and
nasal sinus cancers compared to spouses of
nonsmokers (1,16,17). According to Wallace
(18,19) and Krause et al. (20), indoor ben-
zene concentrations are, respectively, about
50% and 69% higher in smokers’ homes
than in the homes of nonsmokers. Further-
more, tobacco smoke is responsible for 5%
of the total exposure to benzene in the
United States. Smokers receive 89% of their
benzene exposure directly from smoking;
nonsmokers derive about 10% of their
exposure from environmental tobacco smoke
(ETS) (21). Benzene is a hematotoxic sub-
stance that can cause acute myeloid leukemia
and has been classiﬁed as a group A human
carcinogen by EPA (22).
Cigarette smoke and engine exhausts are
the major sources of exposure of the general
population, through inhalation, to 1,3-buta-
diene. EPA has identiﬁed 1,3-butadiene as a
group B2 probable human carcinogen (23)
based on evidence of carcinogenicity from
studies in humans, which indicate a causal
relationship between occupational exposure
to 1,3-butadiene and excess mortality from
lymphatic and/or hematopoietic cancers
(23,24). There is concern over 1,3-butadiene
because it has a unit risk factor 30 times
greater than that for benzene (22,23).
Previous studies have shown that active
cigarette smoking directly affects the levels of
benzene and other volatile organic com-
pounds (VOCs) in breath and blood
(25–28). Because of the dynamic equilib-
rium between the concentration of a VOC
in the blood and its concentration in exhaled
breath (29), breath measurements can be
used to estimate body burden and to detect
changes in body burden with time (30–33).
Although benzene in exhaled air is quite a
good indicator of active smoking (34), there
are too many other sources of benzene in the
environment to make it an effective marker for
the gas phase of ETS or an indicator of passive
smoking (35). Attempts to use nicotine or
cotinine as biomarkers of dose are sometimes
criticized on the grounds that nicotine changes
phase from gas to solid as cigarette smoke ages,
and it deposits on surfaces at variable rates that
depend on local conditions (36,37). It has
therefore been argued that nicotine may not
be a good marker for either the gas or particle
phase of ETS.
In 1990, Gordon (38) evaluated the gas-
phase constituents of smokers’ breath in an
attempt to identify components that could
serve as definitive markers of smoking. Of
the 200-plus chemicals detected in the
breath samples of 26 smokers and 43 non-
smokers, 2,5-dimethylfuran was found to be
a strong indicator of smoking status.
Recently, Ashley et al. (39) analyzed blood
samples from smokers and nonsmokers and
showed that 2,5-dimethylfuran is equally
effective as a blood biomarker for smoking. 
Little is known about the actual levels of
tobacco smoke-related chemicals in smokers’
breath. Information on nonsmokers is even
more sparse. In this pilot study, therefore,
we sought to ﬁll this data gap by using con-
tinuous real-time breath measurement
technology (30,40) to investigate breath
concentrations in active and passive smokers
of the cigarette smoke-associated VOCs ben-
zene and 1,3-butadiene and the smoker
breath biomarker VOC 2,5-dimethylfuran
(38). Our approach was to isolate a smoker
and nonsmoker in a small, unventilated
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We used real-time breath measurement technology to investigate the suitability of some volatile
organic compounds (VOCs) as breath biomarkers for active and passive smoking and to measure
actual exposures and resulting breath concentrations for persons exposed to tobacco smoke.
Experiments were conducted with ﬁve smoker/nonsmoker pairs. The target VOCs included ben-
zene, 1,3-butadiene, and the cigarette smoke biomarker 2,5-dimethylfuran. This study includes
what we believe to be the first measurements of 1,3-butadiene in smokers’ and nonsmokers’
breath. The 1,3-butadiene and 2,5-dimethylfuran peak levels in the smokers’ breath were similar
(360 and 376 µg/m3, respectively); the average benzene peak level was 522 µg/m3. We found
higher peak values of the target chemicals and shorter residence times in the body than previously
reported, probably because of the improved time resolution made possible by the continuous
breath measurement method. The real-time breath analyzer also showed the presence of the
chemicals after exposure in the breath of the nonsmokers, but at greatly reduced levels. Single
breath samples collected in evacuated canisters and analyzed independently with gas chromatogra-
phy/mass spectrometry confirmed the presence of the target compounds in the postexposure
breath of the nonsmokers but indicated that there was some contamination of the breath analyzer
measurements. This was likely caused by desorption of organics from condensed tar in the ana-
lyzer tubing and on the quartz ﬁber ﬁlter used to remove particles. We used the decay data from
the smokers to estimate residence times for the target chemicals. A two-compartment exponential
model generally gave a better ﬁt to the experimental decay data from the smokers than a single-
compartment model. Residence times for benzene, 1,3-butadiene, and 2,5-dimethylfuran ranged
from 0.5 (1,3-butadiene) to 0.9 min (benzene) for τ1 and were essentially constant (14 min) for
τ2. These findings will be useful in models of environmental tobacco smoke exposure and risk.
Key words: active smoking, benzene, 1,3-butadiene, decay, 2,5-dimethylfuran, environmental
tobacco smoke, exhaled breath, passive smoking, pharmacokinetics, real time, uptake. Environ
Health Perspect 110:689–698 (2002). [Online 3 June 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p689-698gordon/abstract.htmlroom and have the smoker smoke four ciga-
rettes in his/her normal manner, with a 20- to
25-min interval between ending one cigarette
and beginning another. After each puff, the
smoker first emptied his or her lungs of
smoke, then breathed into the real-time breath
analyzer while the uptake and decay of the tar-
get chemicals in the blood was monitored.
After each of the first three cigarettes, we
recorded the longer-term decay of the chemi-
cals in the smoker’s breath. On completion of
the fourth and ﬁnal cigarette, we monitored
the nonsmoker’s breath for the same chemicals
and determined the increases in levels of
chemicals caused by the ETS in the room.
Methods
Exposure conditions and breath sampling
protocol. The experiments, which were con-
ducted with five adult smoker/nonsmoker
pairs, were designed to measure the uptake
and decay in real time of the cigarette-associ-
ated target VOCs in the exhaled breath of
each smoker and determine whether expo-
sure to the resulting ETS was measurable in
the breath of the nonsmoker.
The smoker subjects were requested to
refrain from smoking on the morning of the
experiment. For each experiment, a smoker
and nonsmoker were isolated in a small
(24.9 m3), unventilated room. Before expo-
sure to the ﬁrst cigarette began, the smoker
and nonsmoker each provided baseline
breath samples by breathing unﬁltered room
air and exhaling via a standard disposable
mouthpiece into the breath inlet of the real-
time breath analyzer (30,40). We used these
samples to determine background breath
concentrations for each target analyte.
Exposure was initiated by having the
smoker light his or her first cigarette and
puff normally on the cigarette. After each
puff, the first breath exhalation was vented
to the room air to clear the lungs of smoke
and avoid drawing particulate matter into
the breath analyzer. Then the subject
directed the second and subsequent exhala-
tions into the breath analyzer so that the
short-term, postpuff uptake and decay of the
target chemicals in the smoker’s blood could
be monitored. These measurements recorded
the maximum breath concentrations of the
compounds as a function of the individual
puffs taken. Each subject smoked four
cigarettes, ﬁve to seven puffs per cigarette, dur-
ing a 2- to 2.5-hr ad libitum smoking period.
After the ﬁnal puff, the smoker immediately
put on a full face mask (Model 8932; Hans
Rudolph, Inc., Kansas City, MO), and the
longer-term decay of the chemicals in the
smoker’s breath was recorded continuously for
approximately 15 min, while the subject
inhaled hospital-grade breathing air supplied
to the mask from a gas cylinder. After a break
of about 5–10 min, the smoker repeated the
entire sequence two more times. On comple-
tion of the fourth and ﬁnal cigarette, we moni-
tored the nonsmoker’s breath for the same
chemicals with the real-time breath analyzer
and, immediately thereafter, collected a breath
sample using the single breath canister method
(41). Canister samples were subsequently ana-
lyzed by automated gas chromatography/mass
spectrometry (GC/MS) using a modiﬁed ver-
sion of U.S. EPA Method TO-14 (42).
We recruited subjects in pairs through
advertisements in the local university news-
paper. To be eligible, each volunteer pair had
to consist of an active smoker and a non-
smoker companion. Because this was a small
convenience sample, it was not meant to be
representative of any particular population,
and we made no attempt to demographically
match the smoker/nonsmoker pairs.
Information on the participants is pro-
vided in Table 1, along with a summary of
the experimental conditions. The study pro-
tocol was reviewed and approved by the
Battelle Human Subjects Committee, and
informed consent was obtained from each
subject before their participation. Subjects
were free to smoke their usual brand of ciga-
rette. We felt that forcing them to smoke a
single standardized brand with which they
were unfamiliar, in an effort to avoid vari-
ability in smoke composition, would likely
have altered their smoking behavior.
Smokers tend to be very loyal to their brand
choices and attach significant imagery to
particular cigarette brands. That imagery
may well affect the way they smoke a ciga-
rette if a brand is not their usual cigarette.
Before the ﬁrst cigarette was lit and after
cigarettes were smoked during the exposure
sessions, we collected whole-air samples in
the middle of the room using evacuated 6-L
stainless-steel canisters and analyzed the sam-
ples by GC/MS (42). The mean background
concentration for benzene in the room was
2.2 ± 0.5 (SD) µg/m3; background levels for
1,3-butadiene and 2,5-dimethylfuran were
below the detection limits, which for these
whole-air samples were 0.6 µg/m3 for ben-
zene, 0.4 µg/m3 for 1,3-butadiene, and 2.4
µg/m3 for 2.5-dimethylfuran. At the start of
the experiments, the air exchange rate for the
room was determined using the standard sul-
fur hexaﬂuoride tracer technique (43).
The subjects were requested to refrain
from smoking and avoid coffee in the morn-
ing before participating in the experiment.
[2,5-dimethylfuran has been identified by
headspace analysis as a volatile component of
roasted Jamaican coffee beans (44), although
its presence in the exhaled breath of coffee
drinkers has not been established.]
Breath analysis. We have developed spe-
cial monitoring technology to obtain better
time resolution over the uptake and elimina-
tion periods of an exposure episode (30,40).
The technology can measure trace VOCs in
exhaled breath or air continuously in real
time. It consists of a breath inlet unit, a quartz
ﬁber ﬁlter (0.25-µm pore size), a direct breath
sampling interface (glow discharge ionization
source), and a compact ion trap mass spec-
trometer (ITMS) that is capable of operation
in the full tandem (MS/MS) mass spectro-
metric mode (40,45–48). This direct breath
sampling/mass spectrometric approach offers
a powerful means of extracting and quantify-
ing VOCs directly from the breath matrix,
and eliminates the preconcentration step that
normally precedes exhaled air analysis by con-
ventional GC/MS (31,49). To define the
uptake of a compound of interest, all that is
required is to use the real-time breath analyzer
to measure and record the breath levels of a
subject continuously from the start of the
exposure. Information on decay rates may
similarly be obtained from data generated
during the elimination phase.
The quartz ﬁlter, precleaned in a mufﬂe
furnace, was added to the system to prevent
the inﬂux of cigarette smoke particles, which
would otherwise block the inlet oriﬁce of the
glow discharge source. Before the start of
each exposure session with a subject pair, we
replaced the quartz ﬁlter with a clean ﬁlter,
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Table 1. Information on subjects for cigarette smoke exposure study.a
Smoker/nonsmoker Smoker/nonsmoker Cigarette Smoker/nonsmoker Smoker/nonsmoker Smoker/nonsmoker Smoker’s ventilation
pair no. sex brandb age (years) height (m) weight (kg) rate (L/min)c
1 M/M A 20/20 1.75/1.73 68.0/68.0 12.0 ± 2.0
2 M/M B 20/22 1.79/1.83 90.7/72.6 11.2 ± 2.5
3 M/M Cd 26/38 1.65/1.63 59.0/119.3 12.4 ± 2.1
4 F/F A 20/25 1.57/1.68 56.7/52.2 4.1 ± 0.6
5 F/F D 20/20 1.65/1.57 59.0/56.7 7.1 ± 0.5
aVolume of room in which experiments were conducted, 24.9 m3; air exchange rate, 0.62 hr–1; average room temperature, 25.7 ± 0.9ºC. bAll cigarette brands ﬁltered, low tar. cAverage.
dMentholated cigarette; all other nonmentholated cigarettes.and the face mask and tubing to the breath
sampling interface were washed with soap
and water, rinsed with methanol, and air-
dried for at least 12 hr.
For all of the breath measurements
undertaken in this study, except those
immediately following the smoker’s final
puff from a cigarette, a disposable mouth-
piece containing a one-way valve was
attached to the breath inlet to provide a con-
stant source of exhaled air for the mass
spectrometer (30,40). When using the
mouthpiece, the subject inhaled room air
through the nose and exhaled into the
mouthpiece through the mouth.
After the smoker’s ﬁnal puff, a Rudolph
Model 8932 face mask, which contains a
two-way non-rebreathing valve set to isolate
the smoker from the ETS in the room, was
substituted for the mouthpiece. The exhala-
tion valve from the face mask was connected
directly to the breath inlet system by means
of a 15.2-cm (6 in) length of 22-mm (0.9 in)
diameter corrugated polyethylene tubing
(Allied Healthcare, Inc., Toledo, OH). The
inlet valve of the face mask was connected to
a 15-L polyethylene bag that served as a
buffer volume and was attached to a cylinder
containing hospital-grade breathing air. We
used a special head cap joined to the face
mask to ensure a secure and comfortable ﬁt
of the mask to the subject’s face and head
and to reduce strain on the neck muscles.
The entire ﬂow system from the mouthpiece
to the mass spectrometer was heated to pre-
vent condensation of exhaled water vapor
and minimize surface losses of trace-level
organics in the exhaled air.
The undiluted breath sample is vacuum-
extracted at a constant rate from the breath
inlet by the vacuum in the breath sampling
interface and ﬂows into the ion trap without
any attention from the subject. The volume of
the breath inlet is approximately 95 mL, or
roughly one-ﬁfth the mean value of the adult
tidal volume. Thus, each breath exhalation
effectively displaces the previous breath sam-
ple, and a steady gas ﬂow is maintained into
the analyzer. This ensures that unit resolution
is achieved between individual breath exhala-
tions while, at the same time, producing a
constant and undiluted sample for analysis.
We used a dry gas meter (Model DTM-115;
American Meter Co., Horsham, PA), attached
to the vent of the breath inlet system via wide-
bore ﬂexible tubing, to record the total exhaled
volume of breath from each subject.
As noted earlier, the direct breath sam-
pling interface is a glow discharge ionization
source, which is attached to the ITMS. The
operation of this system has been described
in detail elsewhere (47,48,50). The analyzer
is  a Teledyne Electronic Technologies
(Mountain View, CA) 3DQ Discovery ion trap
MS, a compact, ﬁeld-deployable instrument
with high sensitivity and speciﬁcity. We mea-
sured all the target analytes selected for this
investigation in the MS/MS mode. The parent
and product ions that were selected and moni-
tored were m/z 78 and 51 for benzene, m/z 54
and 39 for 1,3-butadiene, and m/z 95 and 67
for 2,5-dimethylfuran. The ion trap was oper-
ated in the dual scan mode, in which two scan
functions are used alternately to control the
instrument. In this mode, the data acquired for
m/z 51 (benzene) and 39 (1,3-butadiene) from
scan function 1 were stored as the Odd scans,
and the data acquired for m/z 67 (2,5-
dimethylfuran) from scan function 2 were
stored as the Even scans. The ion trap was set
to record the average mass spectra for the target
ions once every 6 sec in each scan mode.
Because the levels of the target compounds
were relatively high in the smokers’ breath, we
did not adjust the ion trap for maximum sensi-
tivity (51,52). Consequently, sensitivity was
not optimal for the measurement of these com-
pounds in the breath of the nonsmokers.
The breath analyzer was calibrated with
gas standards of the target compounds that
were prepared in a 186-L glass chamber. In
addition, we collected 6-L samples from the
chamber in evacuated stainless-steel canisters
and analyzed the samples independently for
conﬁrmation using a standard method (42).
We calibrated the instrument each day
before the experiment got underway, then
after each cigarette was smoked.
Background levels for the target ana-
lytes, which were estimated by passing
humidiﬁed ultrahigh purity air through the
entire breath analyzer and measuring the
signals at the masses used to monitor the
compounds, were below the detection limits
for all three compounds. Limits of detec-
tion, estimated by taking three times the
standard deviation of the background con-
centration, were 6.9 µg/m3 for benzene, 3.0
µg/m3 for 1,3-butadiene, and 7.5 µg/m3 for
2,5-dimethylfuran. We set the limit of
quantitation for each compound at three
times the detection limit (53).
To determine the precision of the real-
time technique, we used the glass chamber as
a constant source and recorded the variation
in MS/MS ion signal. By averaging the
results over a suitable time interval, we esti-
mated mean values and standard deviations
for the target analytes, thus providing an
overall measure of system stability and repro-
ducibility. Over a 3.5-hr period, this yielded
a relative standard deviation of 2.2%.
Accuracy was determined by spiking known
volumes of 2,5-dimethylfuran and benzene
into humidiﬁed zero-grade air in the 186-L
glass chamber, then withdrawing 6-L sample
aliquots into evacuated stainless-steel canis-
ters which were analyzed independently,
using GC/MS and traceable standards where
available. The measured concentration as a
fraction of the expected value was 82% for
benzene and 93% for 2,5-dimethylfuran. We
quantiﬁed all concentrations measured using
the real-time system with the results obtained
from the GC/MS analysis of the ITMS gas
calibration standards.
Data analysis. We used the linear mass-
balance multicompartment model, devel-
oped by Wallace et al. (32), to assess the
decay of the target compounds in the blood
and estimate residence times. The compart-
ment model was also used to evaluate impor-
tant parameters that deﬁne the uptake of the
compounds of interest.
For exposure to a constant high concen-
tration, Cair, the multicompartment model
has the following solution:
[1]
where Cbr = exhaled breath concentration of
the component; Cair = concentration of the
component in inhaled air; f = fraction of
inhaled breath concentration exhaled at
equilibrium; ai = fractional contribution of
the ith compartment to the breath at equi-
librium (Σai = 1); t = time from the onset of
exposure; and τi = residence time of the
chemical in the ith compartment. (Cbr is the
mixed expired air, consisting both of alveolar
air and the portion of the pure air supply
that did not undergo alveolar exchange.)
During the postexposure decay phase, the
breath concentration declines exponentially:
[2]
where, now, t is measured from the time
exposure ends. In Equation 2, the ﬁrst term
(compartment) is generally associated with
blood, the second with “highly perfused tis-
sues,” the third with “moderately perfused
tissues,” and the fourth with “poorly per-
fused tissues.” For a broad range of VOCs, it
has been found that the residence times for
these compartments are roughly similar,
namely, 3–11 min for the first compart-
ment, 0.4–1.6 hr for the second, 3–8 hr for
the third, and several days for the fourth
compartment (54). The residence time is
deﬁned as the time it takes for the compound
to decay to 1/e of its initial concentration in
the compartment, assuming all other com-
partments are at zero concentration. The bio-
logical half-life, t1/2, of the compound in the
body is related to the residence time, τ,
through the expression τ = t1/2/ln 2. For the
relatively short exposure times involved in
smoking cigarettes, only the ﬁrst and second
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contributions to the breath levels during the
decay phase.
We determined all the parameters by
first fitting the breath decay data using the
Marquardt-Levenberg (nonlinear regression)
algorithm (SigmaPlot Version 5.0; SPSS,
Chicago, IL), which minimizes the differ-
ences in the sum of squares between the
assumed model and the experimental data.
This provided values for the ai and τi terms
deﬁned in Equation 2.
Wallace et al. (54) have provided a solu-
tion to the multicompartment model for the
case of an exposure at relatively high concen-
trations for a time T followed immediately
by exposure to clean air:
[3]
[4]
where t = time from the start of the expo-
sure, and T = total duration of an exposure
to a constant concentration Cair. 
Cigarette smoking does not normally
subject the smoker to a constant exposure
concentration. Instead, exposure experienced
by a smoker is cyclic—smoking a single ciga-
rette followed by an exposure-free period
before the next cigarette is lit. It is therefore
reasonable to assume that these discrete
activities produce a succession of rises and
declines in the breath levels during the expo-
sure and postexposure periods. As a result,
the breath levels at the end of each exposure
or postexposure segment are described by
the following set of equations (55,56):
[5]
[6]
[7]
[8]
Similarly, for n exposure/postexposure peri-
ods, the equations are:
[9]
[10]
In these equations, t0 denotes the beginning
of the ﬁrst exposure (puff) period, t1 denotes
the end of the ﬁrst exposure period, and (t1 –
t0) is the duration of the first exposure
period. Similarly, (t2 – t1) denotes the dura-
tion of the first postexposure (or breath
sampling) period. In the same manner, 
(t3 – t2) denotes the second exposure period,
and (t4 – t3) is the second postexposure
period. In general, (tn–1 – tn–2) denotes the
(n – 2)th exposure period, and (tn – tn–1)
represents the (n – 2)th postexposure period.
Equations 5–10 are used to simulate the
concentrations in the smokers’ breath as a
result of the cyclic exposure experienced
while smoking successive cigarettes separated
by brief exposure-free intervals.
Results
Smokers. We used the breath analyzer to
monitor the levels of the target analytes in
the exhaled breath of ﬁve active smokers after
each individual puff and during the decay
period after they finished each cigarette.
Figure 1 shows a typical breath concentra-
tion/time proﬁle for benzene, 1,3-butadiene,
and 2,5-dimethylfuran from one of the vol-
unteer smokers. Immediately after each puff,
the smoker first exhaled the smoke, then
breathed into the analyzer, and measure-
ments were taken for 1–2 min to record the
maximum breath levels of the compounds.
Each puff sequence in the plot represents an
episode in which the smoker first drew on
the cigarette and exhaled the smoke (valley
portion of peak). Then, while inhaling room
air, the smoker breathed normally into the
analyzer until the signal passed through a
maximum and began to decrease into the
next valley, when the next puff was taken.
After the final puff from each of the first
three cigarettes, the subject put on the face
mask, and we monitored the elimination of
the compounds from the breath continuously
for about 15 min, until the signal had
returned roughly to its original baseline level.
The plots in Figure 1 and those obtained
for the other smokers monitored show that
the measured breath signals for the target
chemicals closely track each other, suggesting
that the breath benzene and 1,3-butadiene
levels were highly correlated with the breath
levels of the smoke biomarker 2,5-dimethyl-
furan. The occurrence of benzene in the
exhaled breath of both smokers and non-
smokers is well established (25–28,34,35).
However, to the best of our knowledge, these
are the first reported measurements of
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Figure 1. Continuous exhaled breath concentration/time profiles for benzene, 1,3-butadiene, and
2,5-dimethylfuran, obtained from smoker 4 (female, age 20 years) while smoking the third cigarette (ﬁltered,
low tar).
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3rd cigarette1,3-butadiene in human exhaled breath. Two
striking features of these plots are the high
maximum breath concentrations measured
for the target compounds after each puff and
the very rapid decreases in concentration that
occurred for each compound in the period
immediately after active exposure to the
mainstream smoke ended.
Figure 2 shows the average maximum
post-puff breath concentrations of the target
chemicals for each cigarette as a function of
the number of cigarettes smoked by the
smoker from Figure 1 (smoker 4) during the
2- to 2.5-hr exposure session. The maximum
concentration of each compound increased
rapidly with the first cigarette smoked, and
then stayed roughly constant with the
remaining cigarettes smoked in the exposure
event. Figure 3 presents the maximum
breath concentrations of the analytes of
interest in the breath of the active smokers,
averaged over the four cigarettes smoked by
each smoker. The average maximum breath
concentration for benzene varied widely with
smoker, from a low value of 128 µg/m3 (for
smoker 1) to a high value of 886 µg/m3 (for
smoker 4). In contrast, the average breath
level for 1,3-butadiene was relatively con-
stant with smoker, averaging 373 ± 51 (SD)
µg/m3; for 2,5-dimethylfuran, the average
breath level was 375 ± 150 µg/m3.
The breath decay curves after the final
puff from each of the first three cigarettes
smoked by each active smoker were ﬁtted to
the one- and two-compartment curves
described by Equation 2. As an example, the
experimentally measured decay curves are
compared with the modeled curves in Figure
4 for smoker 5 after smoking the third ciga-
rette. The curves show that the breath con-
centrations for all of the chemicals of interest
decreased extremely rapidly with time imme-
diately after exposure. 
The mean residence times, τi, as calcu-
lated from the experimental data, are pre-
sented for the target chemicals in Table 2.
Values obtained for τ1 for benzene, 1,3-buta-
diene, and 2,5-dimethylfuran range from
0.47 min (1,3-butadiene) to 0.88 min (ben-
zene); those for τ2 are essentially constant at
14 min. Estimates of the mean values for the
coefﬁcients, ai, of the exponential terms are
also given in Table 2. Fractional mean values
for a1 range from 0.69 (2,5-dimethylfuran)
to 0.88 (1,3-butadiene). For a2, mean values
range from 0.12 (1,3-butadiene) to 0.31
(2,5-dimethylfuran).
ETS and biomarkers in nonsmokers’
breath. Room air measurements.
Measurements of the air exchange rate for
the room, made using the standard tracer
technique, yielded a value of 0.62 ± 0.07
(SD) air changes per hour. During the expo-
sure sessions with subject pairs 1–3, room air
samples were taken before the ﬁrst cigarette
was smoked and immediately after each ciga-
rette was finished by each smoker to
determine the air concentrations of the com-
pounds of interest. In the case of subject
pairs 4 and 5, only two samples were col-
lected each time during the experiments: the
first before the first cigarette was smoked,
and the second after either the third (subject
pair 4) or fourth cigarette (subject pair 5). 
We collected grab samples each time in
the middle of the room using 6-L stainless-
steel canisters. The measured buildup in the
room air levels of the target compounds dur-
ing each exposure session is presented in
Figure 5. For 1,3-butadiene and 2,5-
dimethylfuran, the air concentrations in all
cases were undetectable before the ﬁrst ciga-
rette is smoked; those for benzene were typi-
cal of indoor concentrations (21). For all
three compounds, the levels increased with
the number of cigarettes smoked. The plots
in Figure 5 suggest that the concentrations
leveled off after the third or fourth cigarette.
The average room air concentrations after
the third and fourth cigarettes are 22.1 ± 6.5
(SD) µg/m3 for benzene and 18.9 ± 9.9
µg/m3 for 1,3-butadiene; the 2,5-dimethyl-
furan levels in the room air are much lower,
on average 5.0 ± 1.3 µg/m3.
The room air concentrations for benzene
and 1,3-butadiene measured in the present
study are similar to those reported in some
earlier studies (2,9,19,20,34), although actual
concentrations are strongly dependent on
room volume, number of cigarettes smoked,
air exchange rates, and so on. In our study,
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Figure 2. Average maximum postpuff breath con-
centration of target chemicals as a function of the
number of cigarettes smoked during the exposure
session by smoker 4. Breath concentrations corre-
sponding to cigarette number 0 were measured
immediately before the ﬁrst cigarette was smoked.
Figure 3. Average maximum postpuff breath con-
centration for benzene, 1,3-butadiene, and 2,5-
dimethylfuran in exhaled breath of active
smokers, averaged over four cigarettes smoked
during each exposure session. Error bars indicate
SD.
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Figure 4. Measured and modeled decay of target chemicals in exhaled breath for smoker 5 after smoking
third cigarette.
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Smoker 5
3rd cigarettewe used a small room and adjusted the venti-
lation rate to a level that is typical of residen-
tial levels (57), in an attempt to obtain
quantifiable ETS-related exposure levels in
the breath of the nonsmokers in the room.
Under these conditions, the average concen-
tration of benzene due to ETS in our experi-
mental room was 19.9 µg/m3 (22.1–2.2
µg/m3 background), about five times the
average concentration of benzene due to ETS
(3.5–4.5 µg/m3) previously measured in a
large number of smokers’ homes (19,20).
Exhaled breath measurements. To
establish whether exposure to ETS is mea-
surable in the breath of the nonsmokers, we
determined the pre- and postexposure breath
levels of the target analytes using the real-
time breath analyzer. Before the first ciga-
rette was lit in the room, a preexposure
breath sample was taken from the smoker
and the nonsmoker. After the smoker’s
fourth cigarette, a postexposure breath sam-
ple again was obtained from the nonsmoker.
At that time, we also collected a whole-
breath sample for GC/MS analysis by
bypassing the breath analyzer and using an
evacuated stainless-steel canister. The breath
analyzer and canister results obtained for the
nonsmokers from subject pairs 1, 2, 4, and 5
are presented in Figure 6. Data are not
included here for nonsmoker 3 because of a
contamination problem that occurred with
the breath samples taken from this subject.
Discussion
Smokers. Breath concentration/time pro-
files. The maximum concentrations of the
target analytes in the breath increase rapidly
with the first cigarette smoked, then stay
roughly constant with the remaining ciga-
rettes smoked during the exposure event.
Figure 3 summarizes the maximum concen-
trations of the chemicals in the breath of the
ﬁve participating smokers, averaged over the
four cigarettes smoked by each smoker.
The effects of cigarette smoking on breath
levels of benzene have been examined in pre-
vious studies. In the Total Exposure
Assessment Methodology (TEAM) study, the
concentration of benzene in breath increased
significantly with the number of cigarettes
smoked (on the day of the breath measure-
ment) (34). A maximum benzene concentra-
tion of 47 µg/m3 was obtained for smokers
who smoked more than 50 cigarettes per day.
The average benzene breath concentration of
smokers in the TEAM study was, however,
only 14 µg/m3 (18). Several other studies
have been reported, including an on-line
study, in which the levels of benzene in smok-
ers’ breath were measured (27,58–62). Breath
benzene concentrations in these studies
ranged from about 5 to 90 µg/m3. In most of
these investigations, breath measurements
commenced at some time after smoking
ceased. In the on-line work reported by
Jordan et al. (59), proton transfer-reaction
mass spectrometry (PTR-MS) was used to
rapidly measure benzene and acetonitrile in
the breath of smokers. Immediately before
smoking a cigarette, the breath benzene levels
were essentially the same as those for non-
smokers. Right after smoking one cigarette,
the benzene concentration rose to about 82
µg/m3 and then decreased rapidly to the
presmoking level. 
These values are signiﬁcantly lower than
the breath benzene levels observed in the
present study. As noted earlier, plots such as
those in Figures 1 and 4 show that the
breath benzene concentration is strongly
time dependent, falling extremely rapidly
with time immediately after each puff is
taken. As a result, the amount of benzene
that will be measurable in the breath is a
strong function of the time elapsed since the
last draw on the cigarette. In the present
study, we started breath measurements just
seconds after each puff was exhaled, resulting
in a more precise deﬁnition of the peak max-
imum and much higher measured concen-
trations of benzene than have been reported
in any previous investigation.
Our measured average maximum concen-
trations for benzene and 1,3-butadiene in the
breath of the participating smokers may be
compared with expected values based on the
inhalable amount present in mainstream
smoke. Two of the cigarette brands used by
the subjects in the current study were
included in the recently completed 1999
Massachusetts Benchmark Study (63). The
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Table 2. Average model decay parameters (mean ± SD) for target chemicals in breath of five smokers,
plus adjusted R2 (range).
Compound a1 (µg/m3) a2 (µg/m3) τ1 (min) τ2 (min) Adjusted R 2
Benzene 444 ± 201 160 ± 61 0.88 ± 0.51 14 ± 4 0.929–0.992
1,3-Butadiene 287 ± 92 40 ± 14 0.47 ± 0.09 14 ± 4 0.953–0.995
2,5-Dimethylfuran 281 ± 159 129 ± 67 0.78 ± 0.22 14 ± 6 0.943–0.987 
35
30
25
20
15
10
5
0
R
o
o
m
 
a
i
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
µ
g
/
m
3
)
024
Cigarette number
3 1 24 3 1 0
35
30
25
20
15
10
5
0
Cigarette number
R
o
o
m
 
a
i
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
µ
g
/
m
3
)
35
30
25
20
15
10
5
0
R
o
o
m
 
a
i
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
µ
g
/
m
3
)
Cigarette number Cigarette number
02 4 3 1 24 3 1 0
35
30
25
20
15
10
5
0
R
o
o
m
 
a
i
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
µ
g
/
m
3
)
35
30
25
20
15
10
5
0
024 3 1
Cigarette number
R
o
o
m
 
a
i
r
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
µ
g
/
m
3
)
A B
C D
E
Benzene
1,3-Butadiene
2,5-Dimethylfuran
Figure 5. Room air concentration of target com-
pounds as a function of the number of cigarettes
smoked during each exposure session. For plots
(A), (B), and (C) (subject pairs 1–3), room air sam-
ples were collected each time before the first
cigarette and immediately after each of the four
cigarettes was smoked; for plots (D) and (E)
(subject pairs 4 and 5), only two samples were
collected during each session.Benchmark Study, which was undertaken to
characterize smoke constituent yield data for
cigarette brands commonly sold in the United
States, involved 26 commercial cigarette
brand styles: 6 mentholated and 20 nonmen-
tholated. Two of the 26 styles tested were
nonﬁltered cigarettes. Standard smoke-yield
parameters (i.e., tar, nicotine, and carbon
monoxide) were measured along with main-
stream and sidestream yields for 41 selected
smoke constituents, including benzene and
1,3-butadiene. If we assume that the 24 ﬁl-
tered cigarette styles tested are representative
of the cigarettes smoked by the subjects in
this study, then the average Benchmark Study
tar content of the cigarettes smoked here was
10.6 mg/cigarette, which corresponds to
mainstream smoke yields of 76 and 74
µg/cigarette for benzene and 1,3-butadiene,
respectively. These values are slightly higher
than the yields of 56 µg per cigarette (range
42–73 µg) for benzene and 65 µg per ciga-
rette (range 54–75 µg) for 1,3-butadiene
obtained earlier by Brunnemann et al. (2,3).
If it takes a typical smoker 10 puffs to
smoke a cigarette, and the volume of each
puff is equal to twice the normal tidal vol-
ume (~500 mL) (57), then the inhaled con-
centration from a cigarette is estimated to be
7,600 µg/m3 for benzene and 7,400 µg/m3
for 1,3-butadiene. Although the estimated
inhaled concentrations for benzene and 1,3-
butadiene are similar, the unit risk factor for
1,3-butadiene is about 30 times higher than
that for benzene (22,23), so that the risk asso-
ciated with exposure to 1,3-butadiene as a
result of active smoking is about 30 times that
for benzene. If we further assume now that
the fractions of inhaled breath benzene and
1,3-butadiene that are exhaled unchanged at
equilibrium are, respectively, equal to about
36% (32,62) and 10% (64), the estimated
exhaled levels are 2,736 µg/m3 for benzene
and 740 µg/m3 for 1,3-butadiene. Although
our measured average maximum breath val-
ues for these chemicals are significantly
higher than any previously recorded in the
breath of smokers, they are still substantially
lower than these estimated levels. It is
important to note, however, that under typi-
cal smoking conditions, the concentrations
in the blood and exhaled breath are nearly
always far from equilibrium, so that the frac-
tion exhaled will be much smaller than pre-
dicted by the value of f. If, for example, the
benzene concentration in the blood is low,
then nearly all of the inhaled benzene will go
into the blood. We therefore expect our
observed values to be a good deal less than
predicted under equilibrium conditions.
Decay curves and residence times. Our
measurements show that the breath concen-
trations of the target compounds decrease
extremely rapidly with time immediately
after each puff. After the ﬁnal puff from each
of the first three cigarettes smoked by each
smoker, continuous breath measurements of
the decay phase were taken from the smoker
for about 15 min while the concentrations of
the compounds of interest decreased to
concentrations that approached the preexpo-
sure levels. The recent PTR-MS on-line
measurements of Jordan et al. (59) also
showed that the benzene concentration is
extremely time dependent, falling rapidly
with time after the last puff on a cigarette. In
Jordon et al.’s study, however, breath mea-
surements were made 4–5 minutes apart, and
the rate of decrease was not as rapid as in our
study; their reported breath levels returned to
the preexposure levels in about 1 hr.
Mean residence times, calculated from
the experimental data, yielded values for τ1
that range from 0.5 min (for 1,3-butadiene)
to 0.9 min (for benzene), while those for τ2
are essentially constant at 14 min. Similar
short residence times for benzene in com-
partment 1 were predicted by Wallace et al.
(32) (2–4 min) and have since been deter-
mined in breath by Lindstrom and Pleil (65)
(2–4 min), Gordon et al. (30) (4–6 min),
and Yu and Weisel (62) (9 min). Sato et al.
(66), using a three-compartment model for
benzene elimination from the blood,
obtained a value of 2 min for τ1. Independent
determinations with which to compare our
residence time for 1,3-butadiene in compart-
ment 1 have not been reported in the litera-
ture. However, Wallace et al. (4,29) have
pointed out that τ1 is on the order of 3–12
min for a number of common nonpolar
VOCs representing three chemical classes
(aromatic, aliphatic, and chlorinated com-
pounds). We can similarly compare our resi-
dence time of 0.8 min for the polar VOC,
2,5-dimethylfuran, in compartment 1 with
values reported in the literature for the polar
VOC, methyl tert-butyl ether, that range
from 2 to 4 min (55,65).
Wallace et al. (4,29) also showed that typi-
cal residence times for compartment 2 are on
the order of 18–120 min for several aromatics,
aliphatics, and chlorinated VOCs. Our mea-
surements yielded a value for τ2 of 14 min for
benzene, 1,3-butadiene, and 2,5-dimethylfu-
ran. Speciﬁc values of τ2 for benzene in com-
partment 2 that have been reported by others
include 43 and 581 min (65), 176 min (30),
and 98 min (62); Sato et al. (66) obtained a
value for τ2 of 30 min for benzene elimination
from the blood. The shorter residence times
obtained in the present study are likely due to
the smaller time resolution and larger number
of measurements made, which allowed us to
extract these times more accurately. The rela-
tively small number of discrete samples taken
in previous studies limited the accuracy and
probably caused some combination of two res-
idence times into one of intermediate length,
whereas the long sample-turnaround times
that occurred in the earliest chamber studies
prevented any measurement of the short ﬁrst-
residence times.
Modeling inhalation exposure from
smoking. We used the estimates for the resi-
dence times and the coefﬁcients of the expo-
nential terms for benzene in Table 2, along
with Equations 9 and 10, to construct a
model of the benzene concentrations in
smokers’ breath as a result of the short-term
cyclic exposure that occurs when smoking a
single cigarette. We set the fraction f in
Equation 9 equal to 0.36 (32,62) and found
that an exposure concentration of 800
µg/m3 gave a reasonable ﬁt to the measured
benzene breath concentrations, as shown for
smoker 1 (1st cigarette) in Figure 7.
The modeled plot in Figure 7 was devel-
oped by ﬁrst obtaining the τi and ai parame-
ters of the model from the decay portion of
the curve, then using these values to estimate
the cyclic uptake and decay segments (55).
The discrete puffs on the cigarette during
the exposure period are responsible for the
sawtooth appearance of the plot. The cycles
are sufﬁciently brief that the breath concen-
trations preceding the 2nd, 3rd, 4th, and 5th
puffs are nonzero and are the reason that
Articles • Breath biomarkers for active and passive smoking
Environmental Health Perspectives • VOLUME 110 | NUMBER 7 | July 2002 695
Figure 6. Effect of exposure to ETS on concentrations of target compounds in exhaled breath of nonsmok-
ers: (A) Pre- and postexposure breath levels measured using the real-time breath analyzer. (B)
Comparison of postexposure breath levels obtained using the real-time breath analyzer with whole-
breath samples collected directly in canisters and analyzed by GC/MS.
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2,5-Dimethylfuran 2,5-Dimethylfuranboth the measured and modeled plots show
a distinct buildup in breath level with each
puff at the upper as well as at the lower end
of each cycle. After the 5th and final puff,
the exposure-free “washout” period is suffi-
ciently long that the breath concentration
returns to the preexposure baseline level.
If we now assume that a typical smoker
smokes a cigarette in 10 min every 30 min
throughout a 16-hr day (equivalent to a 1.5
pack/day smoker), followed by an 8-hr
overnight exposure-free period, we can esti-
mate the concentration of a tobacco smoke
constituent in the exhaled breath of the
smoker from long-term cyclic exposure to
the chemical. For these calculations, we
assumed a four-compartment model with
τ1–τ4 = 3, 30, 180, 3,600 min; a1–a4 = 0.25,
0.25, 0.25, 0.25; f = 0.2; and Cair = 500
µg/m3. The results are summarized in Figure
8, which shows the smoker’s breath levels
immediately before and after each of the 32
cigarettes smoked during the day, for days 1
and 2 and days 14 and 15. In keeping with
the results obtained experimentally, the
breath concentration increases very rapidly
with the ﬁrst few cigarettes, drops down to a
level between 2 and 10 µg/m3 during each 8-
hr exposure-free period, and slowly rises to
reach a constant maximum value (at ~50
µg/m3) on day 15. For this scenario, the
long-term values just before the last cigarette
of the day, presented in Figure 8, are similar
to the values observed earlier with smokers
in the TEAM studies, for whom average
benzene breath concentrations, for example,
were 14 µg/m3 (18).
Nonsmokers. Although most of the pre-
exposure measurements made on the non-
smokers with the real-time breath analyzer
were below the limits of quantitation, as
were some of the postexposure measure-
ments, the data in Figure 6A show that in all
cases, except one, the postexposure concen-
trations were higher than the preexposure
levels. It is not clear why there was no
increase in the breath benzene concentration
after exposure in the case of nonsmoker 1.
The preexposure breath of nonsmoker 2
contained measurable amounts of benzene
and 2,5-dimethylfuran. Because 2,5-
dimethylfuran is not normally measurable in
the breath or blood of nonexposed non-
smokers (38,39), its presence in the breath of
this subject before these measurements were
made suggests that he may have misrepre-
sented himself as a nonsmoker.
We also collected postexposure breath
samples in canisters and analyzed them by
GC/MS, usually within a few days of collec-
tion, for comparison with the breath ana-
lyzer data. The results are shown in Figure
6B. The canister samples confirmed the
presence of the target compounds in the pos-
texposure breath of the nonsmokers. These
breath samples were collected directly from
the subject and did not pass through the ﬁl-
ter or tubing of the breath analyzer.
In virtually every case except two, the
canister concentrations were lower than the
levels measured with the breath analyzer.
Although the canister samples were collected
immediately after the real-time measure-
ments, it is unlikely that the differences
between the two measurements were caused
by changes in concentration with time
because the postexposure canister collections
took place over a relatively flat segment of
the decay curve (Figures 1 and 4). As a
result, changes in breath levels with time
after exposure are assumed to have been
insigniﬁcant. 
For benzene and 1,3-butadiene, the
difference between the canister and the
continuous analyzer may be caused by cont-
amination of the quartz ﬁber ﬁlter and inner
walls of the analyzer tubing with condensed
tar from cigarette smoke that occurred
immediately before these measurements were
made, during the smoker’s exposure session.
This condensate, which presumably adsorbs
the target gases during the exposure periods,
desorbs some of these organic vapors when
uncontaminated air or the nonsmoker’s
breath is then passed through the filter.
Measurements of pure air flowing through
the analyzer, both with and without a clean
ﬁlter, showed that the presence of the ﬁlter
did not contribute to the background levels.
Furthermore, passing a standard of the tar-
get analytes in air through the ﬁlter and tub-
ing, followed by humidified pure air,
showed that the filter did not retain these
VOCs. Because of time constraints, we were
unable to replace the filter and clean the
analyzer system before switching from the
smoker to monitor the nonsmoker’s breath.
It is reasonable to conclude, therefore, that
for these two compounds the higher breath
analyzer levels observed in Figure 6B may
have derived from tar buildup during each
exposure session.
This explanation is not sufﬁcient for the
much greater difference the two methods
display for 2,5-dimethylfuran. Using the
fragment ions at m/z 95 and 67, we were
able to detect 2,5-dimethylfuran unambigu-
ously in our gas standard using the real-time
tandem MS/MS technique. However,
tobacco smoke is an extremely complex mix-
ture, and recent GC/MS analyses of smok-
ers’ breath conducted in our laboratory have
shown that tobacco smoke also includes sev-
eral other compounds that contain m/z 95
and 67 as fragment ions, such as camphene
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Figure 8. Modeled concentration of tobacco smoke constituent in exhaled breath of a regular smoker due
to cyclic exposure as a result of smoking 32 cigarettes in a 16-hr day (i.e., one cigarette in 10 min every 30
min throughout the day, followed by an 8-hr overnight exposure-free period).
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Figure 7. Measured and modeled uptake and decay
of benzene in breath of smoker 1 while smoking
ﬁrst cigarette. See “Discussion” for details.
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Benzene individualized model(1,7,7-trimethylbicyclo[2.2.1]heptane),
limonene [1-methyl-4-(1-methylethenyl)-
cyclohexene], and menthol [5-methyl-2-(1-
methylethyl)-cyclohexanol] in the case of
mentholated cigarettes. Because the MS/MS
technique is unable to distinguish among dif-
ferent chemical species with identical
parent/daughter transitions, the masses we
used here measured the sum of the contribu-
tions from 2,5-dimethylfuran, camphane,
limonene, and others. Although we chose m/z
95 and 67 at the time to give maximum sensi-
tivity for 2,5-dimethylfuran, subsequent
experiments have shown that monitoring the
m/z 96/67 parent/daughter transition would
have yielded greater speciﬁcity and adequate
sensitivity for these analyses. Further tests
indicate that all of the compounds that con-
tribute to the ion signals at m/z 95 and 67
occur only in tobacco smoke, i.e., in active
or passive smokers’ breath, and are not
detected at all in the breath of unexposed
smokers. It is reasonable to assume, there-
fore, that the much greater difference
observed for 2,5-dimethylfuran between the
two measurement methods is due largely to
constituents present in the smoke that con-
tributed as interferents under the monitoring
conditions we used in this work. However,
the generally good agreement obtained for
1,3-butadiene between the two techniques
indicates that further validation of these
methods for 2,5-dimethylfuran in the
tobacco smoke breath matrix is needed.
As noted earlier, the response of the ion
trap was set to accommodate the high con-
centrations of the compounds in the smok-
ers’ breath, and its sensitivity was not
optimal for measuring the lower concentra-
tions of the target compounds in the breath
of the nonsmokers. To monitor these much
lower levels effectively would have required
the development and implementation of a
strategy for optimizing the ion trap operat-
ing parameters (ionization or “gate open”
time, excitation time, excitation voltage,
low-mass cut-off value, ion source tempera-
ture, mass range, and the like) (51,52). For
the present application, which required us
to switch rapidly from the smoker to the
nonsmoker during the exposure sequence, it
was impractical to make these careful
adjustments reproducibly to the instrument
parameters, so the same conditions were
used for each smoker/nonsmoker pair. It
was largely for this reason, rather than the
result of any inherent limitation in the sen-
sitivity of the ion trap mass spectrometer,
that most of the nonsmoker preexposure
measurements made with the breath ana-
lyzer were below the limits of quantitation.
Although the breath analyzer may have
overestimated the postexposure breath
concentrations of the nonsmokers, for the rea-
sons noted above, we nevertheless used the
data to compare the background-corrected
concentrations of benzene, 1,3-butadiene,
and 2,5-dimethylfuran in the breath of the
nonsmoker and smoker during each 2- to 2.5-
hr smoking session. The average increases,
along with their standard deviations, are sum-
marized in Table 3. For each compound,
except 2,5-dimethylfuran for the nonsmokers,
the mean value is greater than two standard
errors of the sample mean, indicating with
about 95% confidence that the exposure
increases were significantly different from
zero. The results also show that for our exper-
imental conditions, the increase in the target
compound concentrations in the smokers’
breath after four cigarettes was at least 12–24
times that in the nonsmokers’ breath.
Conclusions
This study includes what are probably the
first measurements of the carcinogen 1,3-
butadiene in human exhaled breath. The
average peak concentrations of 1,3-butadiene
and benzene in the smokers’ breath were 360
and 522 µg/m3, respectively. The peak values
obtained in this study for breath benzene are
considerably higher than those previously
reported in the literature. The two-compart-
ment model ﬁts both the decay data and the
maxima after each cigarette fairly well for all
three target chemicals. The model further-
more predicts that the peak values will be
reached after about 12–15 cigarettes have
been smoked and that the values will return
to baseline after the 8-hr sleep period.
All three target compounds were
detected in the breath of the nonsmokers
after exposure, using two different types of
sample collection and analysis techniques.
However, these measurements indicated that
there was some contamination of the breath
analyzer, probably due to the buildup of
condensed tar in the system. Future studies
of nonsmokers based on the breath analyzer
will need to take special precautions to avoid
this effect.
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